Tembexa is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Chimerix, Inc.. The primary component is Brincidofovir.
| Product ID | 79622-010_179ef983-ea03-496a-be62-7ce509cea793 |
| NDC | 79622-010 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tembexa |
| Generic Name | Brincidofovir |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-04-20 |
| Marketing Category | NDA / |
| Application Number | NDA214461 |
| Labeler Name | Chimerix, Inc. |
| Substance Name | BRINCIDOFOVIR |
| Active Ingredient Strength | 100 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-04-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 79622-010 | Tembexa | Brincidofovir |
| 79622-012 | Tembexa | Brincidofovir |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TEMBEXA 86800892 4996484 Live/Registered |
Chimerix UK Limited 2015-10-27 |